Profil bibliographique

Raúl Márquez Vázquez

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées

304Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapyCancer Treatment and PharmacologyCancer Immunotherapy and BiomarkersHER2/EGFR in Cancer Research

Publications récentes

Accès ouvert 2026 articleOpenAlex

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial

Shannon N. Westin, J Belotte, Brunella Felicetti, Vishvajit Aghera et autres

0 citationsGynecologic Oncology

2025 articleOpenAlex

1107P Incidence of germline BRCA1/2 mutations in high-grade serous epithelial ovarian cancer (EOC): Final results of the GEICO 60-O/BORNEO study

Ignacio Romero, Raquel López Reig, M.J. Rubio Pérez, Raúl Márquez Vázquez et autres

0 citationsAnnals of Oncology

Accès ouvert 2025 articleOpenAlex

Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch

Sunhee Park, Kian Keyashian, Andrew Ho, David Limsui et autres

1 citationInflammatory Bowel Diseases

Accès ouvert 2025 articleOpenAlex

74MO Prognostic value of PDL1 expression and correlation with HRD status in high-grade serous ovarian cancer: An ancillary analysis of the PAOLA-1/ENGOT-ov25 trial, a GINECO study

I. Treilleux, Stacy Cyrille, Alexis Trécourt, C. Jeanne et autres

0 citationsESMO Open

Accès ouvert 2024 articleOpenAlex

Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin

Nancy M. Y. Teng, Andrea Malfettone, Matthew J. Dalby, Raymond Kiu et autres

1 citationMicrobiome Research Reports

2024 articleOpenAlex

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano, Francesca Galli et autres

127 citationsThe Lancet Oncology

Accès ouvert 2024 articleOpenAlex

55P Long-term responders (LTR) with niraparib maintenance in platinum-sensitive recurrent high-grade serous ovarian cancer (PSROC) focusing on subsequent therapies and post-progression outcomes (GEICO-88R study)

Juan Bañuelos, Yolanda García García, Alfonso Yubero, A. Gallego Martínez et autres

0 citationsESMO Open

Accès ouvert 2024 articleOpenAlex

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial

J Belotte, Brunella Felicetti, Amanda Baines, Ahmed YoussefAgha et autres

5 citationsTrials

Accès ouvert 2023 articleOpenAlex

795P Tolerability and effectiveness of niraparib in long-term responders with platinum-sensitive recurrent ovarian cancer (GEICO-88R study)

Juan Bañuelos, Carmen Salvador Coloma, F. Gálvez Montosa, J. Ferreiro Quintana et autres

1 citationAnnals of Oncology

Accès ouvert 2023 articleOpenAlex

Open-label, phase 2, randomized controlled multicenter study comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in participants with homologous recombination deficient stage III/IV ovarian cancer: Trial in progress (1252)

Xing Zeng, J Belotte, Brunella Felicetti, Amanda Baines et autres

0 citationsGynecologic Oncology

Accès ouvert 2022 articleOpenAlex

14P Gut and oral microbiota profiling in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC) receiving pembrolizumab (P) plus eribulin (E): CALADRIO

Nancy M. Y. Teng, Matthew J. Dalby, Raymond Kiu, T.M. Robinson et autres

4 citationsAnnals of Oncology

2022 articleOpenAlex

Leukemoid reaction with 18F-FDG PET/CT in ovarian carcinoma

L. Reguera Berenguer, Rebeca Pérez Pascual, Juan F. Garcı́a, J. de Santiago García et autres

0 citationsRevista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.